Laboratory measures of hemostasis and fibrinolysis after intravenous administration of E-aminocaproic acid in clinically normal horses and ponies

American Journal of Veterinary Research

Volumn 66, Issue 2, 2005, Pages 313-318

  Heidmann, Peter ^a,b   Tornquist, Susan J ^a   Qu, Annie ^a   Cebra, Christopher K ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; AMINOCAPROIC ACID; D DIMER; FIBRINOGEN; THROMBIN ANTITHROMBIN COMPLEX;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HORSE; LABORATORY TEST; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTEIN FUNCTION; PROTHROMBIN TIME; REFERENCE VALUE; THROMBOCYTE COUNT;

6-AMINOCAPROIC ACID; ANIMALS; ANTIPLASMIN; ANTITHROMBIN III; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; HEMOSTASIS; HORSES; INFUSIONS, INTRAVENOUS; MALE; PARTIAL THROMBOPLASTIN TIME; PEPTIDE HYDROLASES; PLATELET COUNT; PROTHROMBIN TIME;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 14844292572     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.313     Document Type: Article

References (30)

1. Bachmann F. Disorders of fibrinolysis and use of antifibrinolytic agents. In: Beutler E, Lichtman MA, Colter BS, et al, eds. Williams hematology. 6th ed. New York: McGraw-Hill Medical Publishing Division, 2001;1829-1830.
2. Okamoto S, Hijikata-Okunomiya A, Wanaka K, et al. Enzyme-controlling medicines: introduction. Semin Thromb Hemost 1997;23:493-501.
3. Chauhan S, Kumar BA, Rao MS, et al. Efficacy of aprotinin, epsilon aminocaproic acid or combination in cyanotic heart disease. Ann Thorac Surg 2000;70:1308-1312.
4. Ray MJ, O'Brien MF. Comparison of epsilon aminocaproic acid and low-dose aprotonin in cardiopulmonary bypass: efficiency, safety, and cost. Ann Thorac Surg 2001;71:838-843.
5. Downard CD, Betit P, Chang RW, et al. Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review. J Pediatr Surg 2003;38:1212-1216.
6. Harley BJ, Beaupre LA, Jones CA, et al. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. Can J Surg 2002;45:185-190.
7. Pieramici DJ, Goldberg MF, Melia M, et al. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema. Ophthalmology 2003;110:2106-2112.
8. Ray MJ, Hales M, Marsh N. Epsilon-aminocaproic acid promotes the release of alpha 2-antiplasmin during and after cardiopulmonary bypass. Blood Coagul Fibrinolysis 2001;12:129-135.
9. Slaughter TF, Faghih F, Greenberg CS, et al. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg 1997;85:1221-1226.
10. Latimer KS, Mahaffey GA, Prasse KW. Proteins, lipids, and carbohydrates. In: Duncan and Prasse's veterinary laboratory medicine: clinical pathology. 4th ed. Ames, Iowa: Iowa State University Press, 2003;162-193.
11. Freyburger G, Trillaud H, Labrouche S, et al. D-dimer strategy in thrombosis exclusion-a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost 1998;79:32-37.
12. Kovacs MJ, MacKinnon KM, Anderson D, et al. A comparison of three rapid D-dimer methods for the diagnosis of venous thromboembolism. Br J Haematol 2001;115:140-144.
13. Topper MJ, Prasse KW. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic. Am J Vet Res 1996;57:456-462.
14. Topper MJ, Prasse KW, Morris MJ, et al. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses. Am J Vet Res 1996;57:427-431.
15. Grabowski EF, Hilgartner MW. Thrombosis and children. In: Kwaan HC, Samana MM, eds. Clinical thrombosis. Boca Raton, Fla: CRC Press Inc, 1989;305-315.
16. Lowe GDO, Rumley A. Fibrinogen and its degradation products as thrombotic risk factors. In: Nieuwenhuizen W, Mosesson MW, De Maat MPM, eds. Fibrinogen: XVIth International Fibrinogen Workshop. Vol 936. New York: New York Academy of Sciences, 2001;560-565.
17. Rothwell SW, Fudge JM, Reid TJ, et al. E-Amino caproic acid additive decreases fibrin bandage performance in a swine arterial bleeding model. Thromb Res 2002;108:341-345.
18. Glick R, Green D, Ts'ao C, et al. High dose E-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage. Neurosurgery 1981;9:398-400.
19. Stefanini M, Dameshek W. The hemostatic disorders. 2nd ed. New York: Grune & Stratton, 1962;510-514.
20. Phillips D, Tebbett IR, Kalita S. Solid phase extraction and analysis of horse urine for aminocaproic acid. Chromatographia 1990;30:309-317.
21. Aminocaproic acid. In: Novak KK, ed. Drug facts and comparisons 2003. 57th ed. St Louis: Wolters Kluwar Co, 2003;231-232.
22. Lee KN, Jackson KW, McKee PA. Effect of a synthetic carboxy-terminal peptide of α2-antiplasmin on urokinase-induced fibrinolysis. Thromb Res 2002;105:263-270.
23. Prasse KW, Allen D, Moore JN, et al. Evaluation of coagulation and fibrinolysis during the prodromal stages of carbohydrate-induced acute laminitis in horses. Am J Vet Res 1990; 51:1950-1955.
24. Amar D, Grant FM, Zhang H, et al. Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery. Anesthesiology 2003;98:337-342.
25. Lee KN, Lee CS, Tae WC, et al. Crosslinking of α2-antiplasmin to fibrin. In: Nieuwenhuizen W, Mosesson MW, De Maat MPM, eds. Fibrinogen: XVIth International Fibrinogen Workshop. Vol 936. New York: New York Academy of Sciences, 2001; 335-339.
26. Meyers KM, Menard M, Wardrop KJ. Equine hemostasis. Description, evaluation, and alteration. Vet Clin North Am Equine Pract 1987;3:485-505.
27. Liu G, Bowkett J, Przybylowski G, et al. Postoperative fibrinolysis diagnosed by thrombelastography. Anaesth Intensive Care 2000;28:77-81.
28. King C. Exercise induced pulmonary hemorrhage: rational approach to therapy. J Equine Vet Sci 1995;15:7-12.
29. van den Burg FJ, Hospers JE, Mosterd WL, et al. Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction products. J Appl Phys 2000;88:1558-1564.
30. El-Sayed MS, Sale C, Jones PG, et al. Blood hemostasis in exercise and training. Med Sci Sports Exer 2000;32:918-925.